分叉血管支架市场规模、份额、成长分析（按设备类型、材料、应用、地区）- 产业预测，2025-2032 年

Branched Stent Grafts Market Size, Share, Growth Analysis, By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE)), By Application, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月27日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023年全球分叉血管支架市场规模为3.2439亿美元，从2024年的3.4937亿美元成长到2032年的6.3242亿美元，预测期（2025-2032）预计复合年增长率为7.7%。

分叉血管支架市场最初是为治疗主动脉病变而开发的，由于血管内主动脉修復（EVAR）的兴起和患者照护技术的进步，分叉覆膜支架市场经历了显着增长。这种创新治疗方法扩大了 EVAR 在大型胸动脉瘤和动脉夹层治疗中的应用，特别是针对老龄化人口中主动脉和腹部动脉瘤患病率日益增加的问题。然而，Covid-19大流行的爆发阻碍了市场进展，导致销售下降和择期手术延迟。儘管面临这些挑战，由于对微创手术的需求不断增加，市场正在復苏，未来几年将为市场扩张带来重大机会。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2022-2024）

主要企业简介

Medtronic plc
Cook Medical
WL Gore & Associates, Inc.
Endologix, Inc.
JOTEC GmbH
LeMaitre Vascular, Inc.
MicroPort Scientific Corporation
Terumo Corporation
Vascutek, Ltd.
Zenith（Cook Medical）
TriVascular Technologies, Inc.
Bolton Medical
Lombard Medical, Inc.
QualiMed Innovative Medizinprodukte GmbH
Nano Endoluminal, SL

结论和建议

简介目录

Product Code: SQMIG35G2108

Global Branched Stent Grafts Market size was valued at USD 324.39 Million in 2023 and is poised to grow from USD 349.37 Million in 2024 to USD 632.42 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The branched stent graft market, initially developed for treating aortic lesions, is experiencing significant growth due to an increasing number of endovascular aortic repair (EVAR) procedures and technological advancements in patient care. This innovative treatment expands EVAR applications for pectoral aneurysms and arterial dissections, addressing the rising prevalence of aortic and abdominal aneurysms, particularly among the aging population. However, the onset of the COVID-19 pandemic hindered market progress, leading to decreased sales and delayed elective surgeries. Despite these challenges, the market is poised for recovery, driven by a growing demand for minimally invasive surgical options, which presents substantial opportunities for market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Branched Stent Grafts Market Segmental Analysis

Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market is experiencing significant growth, primarily driven by the increasing number of endovascular aneurysm repair (EVAR) procedures. This uptick can be attributed to enhancements in patient care quality and continual advancements in medical technology, which improve procedural outcomes. Additionally, the ageing population is a crucial factor contributing to market expansion, as older individuals are more susceptible to health issues such as abdominal aortic aneurysms (AAA). Consequently, the combination of these elements is fostering a conducive environment for the continued development and adoption of branched stent grafts within the healthcare landscape.

Restraints in the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market faces significant challenges due to high costs associated with endovascular aneurysm repair procedures. These expenses often render such treatments unaffordable for middle- and lower-income individuals, limiting their access to vital medical interventions. As a result, the financial burden acts as a major restraint on the growth of the branched stent grafts market, as many potential patients may opt for alternative, less costly options or forego treatment altogether. This financial barrier ultimately impacts market demand and hinders the overall expansion of branched stent graft technologies within the healthcare landscape.

Market Trends of the Global Branched Stent Grafts Market

The Global Branched Stent Grafts market is witnessing significant growth driven by the increasing adoption of minimally invasive procedures like AEVAR, BEVAR, and TEVAR for aneurysm treatment. These advanced techniques offer patients safety, efficacy, and cost-effectiveness, appealing to both healthcare providers and patients alike. The demand for Image guidance technologies, such as X-rays, further enhances procedural success, solidifying branched stent grafts as essential tools in vascular interventions. As awareness of vascular diseases grows and technology advances, the market for branched stent grafts is poised for expansion, making it a key area of investment for medical device manufacturers and healthcare providers globally.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Branched Stent Grafts Market Size by Device Type & CAGR (2025-2032)

Market Overview
Aortic Branched Stent Grafts
Iliac Branched Stent Grafts
Femoral Branched Stent Grafts
Global Branched Stent Grafts Market Size by Material & CAGR (2025-2032)
Market Overview
Nitinol
Polytetrafluoroethylene (PTFE)
Polyester

Global Branched Stent Grafts Market Size by Application & CAGR (2025-2032)

Market Overview
EVAR
Chimney
Fenestrated Endovascular Aortic Aneurysm Repair
Others

Global Branched Stent Grafts Market Size & CAGR (2025-2032)

North America (Device Type, Material, Application)
- US
- Canada
Europe (Device Type, Material, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Device Type, Material, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Device Type, Material, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Device Type, Material, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JOTEC GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LeMaitre Vascular, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascutek, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zenith (Cook Medical)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriVascular Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bolton Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lombard Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QualiMed Innovative Medizinprodukte GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nano Endoluminal, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments